Gebelikte Hipertansif Hastalıkların Tanısı ve Yöntemi

Year 2018, Volume: 4 Issue: 1, 1 - 8, 23.03.2018

Hilal Uslu Yuvacı

Abstract

Gebelikte en sık karşılaşılan medikal komplikasyon hipertansiyondur. Gebelikte hipertansif hastalıkların görülme insidansı tüm dünyada giderek artmaktadır. Hipertansiyon maternal morbidite ve mortaliteyi anlamlı derecede etkiler. Hipertansif gebe hastanın yönetiminde maternal uç organları koruyacak düzeyde bir kan basıncı sağlamak anahtar rol oynayacaktır. Bu amaçla makalemizde gebelikteki hipertansif hastlalıkların sınıflandırılması tanısı ve yönetim stratejilerini güncel klavuzlar eşliğinde tanımladık. 

Keywords

Hipertansiyon, gebelik, preeklampsi, eklampsi

Diagnosis And Management Of Hypertension In Pregnancy

Abstract

The most common medical complication of pregnancy is hypertension. The incidence of hypertensive disorders in pregnancy is increasing all over the world. Hypertension significantly affects maternal morbidity and mortality. Provide enough blood pressure for protecting maternal end organ will play a key role in management of hypertensive pregnant patients. To this end, in this paper we describe the classification of the hypertensive disorders, diagnosis and management in pregnancy in the light of current guidelines.

Keywords

Hypertension, pregnancy, preeclampsia, eclampsia

References

• 1. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London; 2011.
• 2. Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis 2013; 20(3): 229-39.
• 3. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33(3): 130-7.
• 4. American College of O, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122(5): 1122-31.
• 5. Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs 2014; 74(3): 283-96.
• 6. Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol 2013; 25(2): 124-32.
• 7. Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Pregnancy 2012; 2012: 105918.
• 8. The Diagnosis and Management of Pre-eclampsia and Eclampsia Clinical Practice Guideline. Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Clinical Strategy and ProgrammesDirectorate, Health Service Executive, 2013.
• 9. Vest AR, Cho LS. Hypertension in pregnancy. Cardiol Clin 2012; 30(3): 407-23.
• 10. Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyr GJ. Pre-eclampsia. Lancet 2015.
• 11. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102(1): 181-92.
• 12. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007; (1): CD002252.
• 13. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007; 196(6): 514 e1-9.
• 14. Ganzevoort W, Sibai BM. Temporising versus interventionist management (preterm and at term). Best Pract Res Clin Obstet Gynaecol 2011; 25(4): 463-76.
• 15. Publications Committee SfM-FM, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol 2011; 205(3): 191-8.
• 16. Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia- eclampsia. Am J Obstet Gynecol 2009; 200(5): 481 e1-7.
• 17. Martin J, Sidman R. Late postpartum eclampsia: a common presentation of an uncommon diagnosis. J Emerg Med 2003; 25(4): 387-90.
• 18. Chhabra S, Tyagi S, Bhavani M, Gosawi M. Late postpartum eclampsia. Jb Obstet Gynaecol 2012; 32(3): 264-6.
• 19. Brewer J, Owens MY, Wallace K, et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 2013; 208(6): 468 e1-6.
• 20. Staykov D, Schwab S. Posterior reversible encephalopathy syndrome. J Intensive Care Med 2012; 27(1): 11-24.
• 21. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334(8): 494-500.
• 22. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008; 29(6): 1036-42.
• 23. Liman TG, Bohner G, Heuschmann PU, Scheel M, Endres M, Siebert E. Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases. Eur J Neurol 2012; 19(7): 935-43.
• 24. Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2007; 33(2): 230-6.
• 25. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001; 24(5): 361-4.
• 26. Seely EW, Ecker J. Clinical practice. Chronic hypertension in pregnancy. N Engl J Med 2011; 365(5): 439-46.
• 27. Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, Haddad B. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS One 2013; 8(5): e62140.
• 28. Catov JM, Nohr EA, Olsen J, Ness RB. Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol 2008; 112(2 Pt 1): 290-6.
• 29. Hedderson MM, Ferrara A. High blood pressure before and during early pregnancy is associated with an increased risk of gestational diabetes mellitus. Diabetes Care 2008; 31(12): 2362-7.
• 30. Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versusexpectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374(9694): 979-88.
• 31. Barton JR, O’Brien J M, Bergauer NK, Jacques DL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001; 184(5): 979-83.
• 32. Magee LA, Abalos E, von Dadelszen P, et al. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011; 72(3): 394-401.
• 33. Nabhan AF, Elsedawy MM. Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension. Cochrane Database Syst Rev 2011; (7): CD006907.
• 34. Magee LA, Namouz-Haddad S, Cao V, Koren G, von Dadelszen P. Labetalol for hypertension in pregnancy. Expert Opin Drug Saf 2015; 14(3): 453-61.
• 35. Olson-Chen C, Seligman NS. Hypertensive Emergencies in Pregnancy. Crit Care Clin 2016; 32(1): 29-41.
• 36. Committee on Obstetric P. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2015; 125(2): 521-5.
• 37. Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 1999; 181(4): 858-61.
• 38. Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2013; 7: CD001449.
• 39. Nij Bijvank SW, Duvekot JJ. Nicardipine for the treatment of severe hypertension in pregnancy: a review of the literature. Obstet Gynecol Surv 2010; 65(5): 341-7.
• 40. Magee LA, Miremadi S, Li J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005; 193(1): 153-63.
• 41. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105(2): 402-10.
• 42. Ames M, Rueda J, Caughey AB. Ambulatory management of chronic hypertension in pregnancy. Clin Obstet Gynecol 2012; 55(3): 744-55.
• 43. Barr M, Jr. Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 1994; 50(6): 399-409.
• 44. Podymow T, August P. Antihypertensive drugs in pregnancy. Semin Nephrol 2011; 31(1): 70-85.
• 45. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990; 162(4): 960-6; discussion 6-7.
• 46. Redman CW. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976; 2(7989): 753-6.
• 47. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev 2007; (1): CD004451.
• 48. Serreau R, Luton D, Macher MA, Delezoide AL, Garel C, Jacqz-Aigrain E. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG 2005; 112(6): 710-2.